🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Inserting a gene that has been created in the laboratory into a ...
Status
Completed
Location
Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office
Start Date
2004-05
Trial ID
NCT00085462
This phase I trial studies the side effects and best dose of autologous den...
Status
Active Not Recruiting
Location
UCLA / Jonsson Comprehensive Cancer Center
Start Date
2019-07-08
Trial ID
NCT03546361
Treatments Being Tested
This research study is to determine the safety and dosage of special cells ...
Status
Completed
Location
Texas Children's Hospital GCRC
Start Date
1999-06
Trial ID
NCT00058799
Treatments Being Tested
This study was designed to assess the safety and efficacy of inactivated tu...
Status
Completed
Location
N.N. Petrov Research Institute of Oncology Chemotherapy and Innovative Technologies Department
Start Date
2001-01-31
Trial ID
NCT04180774
Treatments Being Tested
Background: * Flutamide is an approved drug for prostate cancer that block...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2007-02-23
Trial ID
NCT00450463
Treatments Being Tested
RATIONALE: Inserting a laboratory-treated gene into a person's white blood ...
Status
Completed
Location
Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office
Start Date
2004-07
Trial ID
NCT00091104
Treatments Being Tested
This pilot phase I trial studies the side effects of taking ipilimumab afte...
Status
Terminated
Location
Jonsson Comprehensive Cancer Center
Start Date
2014-07-17
Trial ID
NCT02070406
Rationale: Vaccines made from gene-modified tumor cells may help the body b...
Status
Completed
Location
Southern Cancer Center
Start Date
2008-07
Trial ID
NCT00676507
Treatments Being Tested
RATIONALE: Interleukin-2 may stimulate a person's white blood cells includi...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
1995-01
Trial ID
NCT00002637
Treatments Being Tested
This is a research study to determine the safety and dosage of special cell...
Status
Completed
Location
The Methodist Hospital
Start Date
2002-12
Trial ID
NCT00058786
Treatments Being Tested